BRAINSTORM CELL THERAPEUTICS INC.: BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Comprehensive Corporate Update

BrainStorm Cell Therapeutics Inc. issued the following announcement on Nov. 5.

BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that the Company will hold a conference call to update shareholders on financial results for the third quarter ended September 30, 2019, and provide a corporate update, at 8:00 a.m., Eastern Standard Time, on Thursday, November 14, 2019.

BrainStorm’s President & CEO, Chaim Lebovits, will present a corporate update, after which, participant questions will be answered. Joining Mr. Lebovits to answer investment community questions will be Ralph Kern, MD, MHSc, Chief Operating Officer and Chief Medical Officer, and Preetam Shah, PhD, Chief Financial Officer.

Participants are encouraged to submit their questions prior to the call by sending them to:; Questions should be submitted by 5:00 p.m., Eastern Standard Time, Tuesday, November 12.

The investment community may participate in the conference call by dialing the following numbers:

Toll Free:Toll Free: 1-877-423-9813
Audio Webcast:Link to Webcast
Those interested in listening to the conference call live via the internet may do so by visiting the “Investors & Media” page of BrainStorm’s website at and clicking on the conference call link.

A webcast replay of the conference call will be available for 30 days on the “Investors & Media” page of BrainStorm’s website:

Toll Free:1-844-512-2921
Replay Pin Number:13696529
Replay Start:Thursday, November 14, 2019, 11:00 AM ET
Replay Expiry:Thursday, November 28, 2019, 11:59 PM ET

Original source can be found here.

Want to get notified whenever we write about BrainStorm Cell Therapeutics Inc. ?

Sign-up Next time we write about BrainStorm Cell Therapeutics Inc., we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

BrainStorm Cell Therapeutics Inc.

More News

Metro Business Network